ZNF138
gene geneOn this page
Also known as pHZ-32
Summary
ZNF138 (zinc finger protein 138, HGNC:12922) is a protein-coding gene on chromosome 7q11.21, encoding Zinc finger protein 138 (P52744). May be involved in transcriptional regulation as a repressor.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in membrane and nucleus.
Source: NCBI Gene 7697 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_001271639
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12922 |
| Approved symbol | ZNF138 |
| Name | zinc finger protein 138 |
| Location | 7q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | pHZ-32 |
| Ensembl gene | ENSG00000197008 |
| Ensembl biotype | protein_coding |
| OMIM | 604080 |
| Entrez | 7697 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000307355, ENST00000359735, ENST00000430838, ENST00000437743, ENST00000440155, ENST00000440598, ENST00000494380
RefSeq mRNA: 11 — MANE Select: NM_001271639
NM_001160183, NM_001271637, NM_001271638, NM_001271639, NM_001271640, NM_001271649, NM_001367572, NM_001367574, NM_001367575, NM_001367577, NM_006524
CCDS: CCDS34645, CCDS55115, CCDS64659, CCDS64660, CCDS64661, CCDS75607
Canonical transcript exons
ENST00000307355 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001849210 | 64831451 | 64833680 |
| ENSE00003600414 | 64794428 | 64794571 |
| ENSE00003687201 | 64815576 | 64815653 |
| ENSE00003733988 | 64814918 | 64815044 |
Expression profiles
Bgee: expression breadth ubiquitous, 243 present calls, max score 88.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.2663 / max 448.9475, expressed in 1737 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 78816 | 17.0826 | 1714 |
| 78817 | 1.9856 | 739 |
| 78815 | 1.1042 | 608 |
| 204459 | 0.0940 | 21 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ganglionic eminence | UBERON:0004023 | 88.96 | gold quality |
| cortical plate | UBERON:0005343 | 87.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.27 | gold quality |
| ventricular zone | UBERON:0003053 | 85.22 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.24 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.99 | gold quality |
| corpus callosum | UBERON:0002336 | 80.80 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.59 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 80.27 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 79.78 | gold quality |
| spinal cord | UBERON:0002240 | 78.94 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 78.67 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.75 | gold quality |
| skin of abdomen | UBERON:0001416 | 77.70 | gold quality |
| substantia nigra | UBERON:0002038 | 77.01 | gold quality |
| cerebellar vermis | UBERON:0004720 | 76.69 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 76.47 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 76.44 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.42 | gold quality |
| adrenal gland | UBERON:0002369 | 76.39 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.27 | gold quality |
| secondary oocyte | CL:0000655 | 76.20 | gold quality |
| lymph node | UBERON:0000029 | 76.19 | gold quality |
| rectum | UBERON:0001052 | 76.10 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 76.10 | gold quality |
| tonsil | UBERON:0002372 | 76.06 | gold quality |
| amygdala | UBERON:0001876 | 75.93 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 75.92 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 75.90 | gold quality |
| sperm | CL:0000019 | 75.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
75 targeting ZNF138, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 138 — P52744 (reviewed: P52744)
All UniProt accessions (6): A0A0A0MRG3, A0A0A0MT90, C9JHF6, E7EWC5, P52744, J3QSS9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation as a repressor.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P52744-1 | 1 | yes |
| P52744-2 | 2 | |
| P52744-3 | 3 |
RefSeq proteins (10): NP_001153655, NP_001258566, NP_001258567, NP_001258568, NP_001258569, NP_001354501, NP_001354503, NP_001354504, NP_001354506, NP_006515 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13912
UniProt features (14 total): zinc finger region 6, sequence conflict 3, splice variant 3, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P52744-F1 | 68.84 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 98 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, FISCHER_DREAM_TARGETS, chr7q11, XU_GH1_AUTOCRINE_TARGETS_DN, TGGAAA_NFAT_Q4_01, HAMAI_APOPTOSIS_VIA_TRAIL_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, ZWANG_DOWN_BY_2ND_EGF_PULSE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CBX5_TARGET_GENES, CEBPZ_TARGET_GENES, CHAMP1_TARGET_GENES
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
61 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DHPS | ZNF138 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF138 | ZBTB8A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | KRTAP12-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | ELOA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | LHX6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | BCCIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAPK9 | ZNF138 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | ZNF138 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF138 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | ZNF138 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (25): ZNF138 (Two-hybrid), ZNF138 (Two-hybrid), TRIM41 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZBTB8A (Two-hybrid), ZNF138 (Two-hybrid), ZNF138 (Two-hybrid), ZNF138 (Two-hybrid), ZNF138 (Two-hybrid), ZNF138 (Two-hybrid), ZNF138 (Two-hybrid), ZNF138 (Two-hybrid), ZNF138 (Two-hybrid)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A7MBI1, A8MUZ8, A8MWA4, B2RXC5, E7ETH6, E9Q8G5, O14628, P0CB33, P0CH99, P0CI00, P21506, P51508, P52744, Q02525, Q0D2J5, Q12901, Q13360, Q15973, Q2M218, Q2VY69, Q4R882, Q5FWF6, Q5HY98, Q5JVG8, Q6P280, Q6V9R5, Q6ZN11, Q6ZN79, Q86XU0, Q8IVC4, Q8IW36, Q8IYX0, Q8N587, Q8N782, Q8N859, Q8NB42, Q8NDP4, Q8NE65
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1308 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:64814993:A:T | donor_gain | 1.0000 |
| 7:64815043:GG:G | donor_gain | 1.0000 |
| 7:64815044:GG:G | donor_gain | 1.0000 |
| 7:64815045:G:GG | donor_gain | 1.0000 |
| 7:64815045:GT:G | donor_loss | 1.0000 |
| 7:64815046:T:G | donor_loss | 1.0000 |
| 7:64817334:GA:G | donor_gain | 1.0000 |
| 7:64817336:G:GG | donor_gain | 1.0000 |
| 7:64831074:GAT:G | donor_gain | 1.0000 |
| 7:64831450:GCTCT:G | acceptor_gain | 1.0000 |
| 7:64794537:C:G | donor_gain | 0.9900 |
| 7:64794573:T:G | donor_loss | 0.9900 |
| 7:64814906:C:CA | acceptor_gain | 0.9900 |
| 7:64814912:TTTCA:T | acceptor_loss | 0.9900 |
| 7:64814913:TTCA:T | acceptor_loss | 0.9900 |
| 7:64814914:TCAGG:T | acceptor_loss | 0.9900 |
| 7:64814915:CA:C | acceptor_loss | 0.9900 |
| 7:64814916:A:AG | acceptor_gain | 0.9900 |
| 7:64814916:AG:A | acceptor_gain | 0.9900 |
| 7:64814916:AGG:A | acceptor_gain | 0.9900 |
| 7:64814917:G:GG | acceptor_gain | 0.9900 |
| 7:64814917:GG:G | acceptor_gain | 0.9900 |
| 7:64814917:GGG:G | acceptor_gain | 0.9900 |
| 7:64814917:GGGAC:G | acceptor_gain | 0.9900 |
| 7:64815005:C:T | donor_gain | 0.9900 |
| 7:64815047:G:GG | donor_loss | 0.9900 |
| 7:64815554:A:G | acceptor_gain | 0.9900 |
| 7:64815570:A:G | acceptor_gain | 0.9900 |
| 7:64817329:TTACA:T | donor_gain | 0.9900 |
| 7:64820218:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
2129 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000048354 (7:64807939 AT>A), RS1000064909 (7:64830597 A>G), RS1000079610 (7:64815318 C>T), RS1000148791 (7:64814087 C>T), RS1000181768 (7:64850312 C>T), RS1000210284 (7:64812385 C>T), RS1000226067 (7:64832297 C>A,T), RS1000283630 (7:64797753 CAA>C), RS1000332403 (7:64817809 A>T), RS1000373904 (7:64861323 G>C), RS1000412837 (7:64850121 T>C), RS1000585703 (7:64845530 A>G), RS1000633860 (7:64792743 G>T), RS1000653959 (7:64844130 G>A), RS1000671681 (7:64819111 G>T)
Disease associations
OMIM: gene MIM:604080 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, increases expression | 3 |
| Cadmium Chloride | increases abundance, increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Lycopene | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression, affects cotreatment | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Clorgyline | increases expression | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD09 | HEK293 eGFP-ZNF138 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.